contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


modulight-to-publish-its-interim-report-for-january-september-2025-on-october-24-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.

Er der sket nogen større udvikling eller noget værd at nævne i samarbejdet mellem IQM og Modulight inden for kvanteberegning, eller er det bare et grundlæggende samarbejde? Der er set nogle artikler om emnet.

God virksomhedspræsentation. Udstråler selvtillid. Huskede også talerne om kommercialisering fra 2024. Sagde nu, at der indtil videre ikke har været noget at offentliggøre.

Ny, lige under en halv time med Modu og Orsila.https://youtu.be/tk0nQENR9DU?si=9MU7U32q6KifMSdf&t=4

Min tidligere besked i tråden for 4 år siden. Modu designer lasere, hvilket potentielt er en meget lukrativ del af værdikæden, hvis de kan skille sig ud. Jeg ser dog ingen tegn på det endnu. Hvem har fundet ud af, hvad der bliver lavet på Modus fabrik? De reklamerer med at være ”vertically integrated”, men det kan umuligt passe. Det er nok samling. De kritiske instrumenter kommer vel andre steder fra. Årsrapporten er dækket af ESG-vrøvl, jeg kan simpelthen ikke få klarhed over sagen. Hvem ved? tab 2x omsætning. For mig er Modu stadig ikke et investeringsværdigt selskab.

Jeg investerede også for nylig lidt i Modulight. Jeg har også selv lagt mærke til stilheden, tydeligvis det mest stille selskab blandt mine investeringer.

Der er stille, beklageligvis stille. Omsætningen er næsten på nul. Sådan går årene, store løfter er blevet til stilhed.

Orsila har købt 21.000 stk. Et godt tegn for mig.

Modulight

Modulight Corporation | Press Release | October 20, 2025 at 11:20:00 EESTModulight Corporation will publish its interim report for January–September 2025 on Friday, October 24, 2025, approximately...

<div class="mfn-header mfn-header-finland"><p>Modulight Corporation | Press Release | October 20, 2025 at 11:20:00 EEST</p></div><div class="mfn-body"><p>Modulight Corporation will publish its interim report for January–September 2025 on Friday, October 24, 2025, approximately at 1:00 p.m. EEST.</p><p>Modulight's CEO Seppo Orsila will present the result in an English-language webcast on October 24, 2025, at 2:30 p.m. EEST. The broadcast can be followed at <a rel="noopener" href="https://modulight.zoom.us/webinar/register/WN_59ctJvXhSU6dzQ78XJAhSw">https://modulight.zoom.us/webinar/register/WN_59ctJvXhSU6dzQ78XJAhSw</a>.</p><p>Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at <a rel="noopener" href="http://modulight.com/reports-presentations/">modulight.com/reports-presentations/.</a></p></div><div class="mfn-footer mfn-contacts mfn-94b966cad316"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>CEO Seppo Orsila m. +358 40 830 4671<br>CFO Anca Guina m. +358 40&nbsp;830 4674<br>IR Ulla Haapanen m. +358 40 830 4676<br>Email: <a rel="noopener" href="mailto:ir@modulight.com">ir@modulight.com</a></p></div><div class="mfn-footer mfn-about mfn-f80935501c1c"><p><strong class="mfn-heading-1">Modulight in brief</strong></p><hr><p>Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.</p><p>Follow&nbsp;Modulight: <a rel="noopener" href="https://modulight.com">modulight.com</a> | <a rel="noopener" href="https://twitter.com/modulight">X&nbsp;</a>|&nbsp;<a rel="noopener" href="https://www.linkedin.com/company/modulight/">LinkedIn</a> | <a rel="noopener" href="https://www.facebook.com/modulight.inc">Facebook</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.youtube.com/Modulight">YouTube</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.instagram.com/modulight.inc/">Instagram</a>&nbsp;| #killcancer #laserfamily</p></div>